# BIXLENVO

NDC: 61958-3601
Generic name: bictegravir/lenacapavir
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260827

FDA application: NDA221104

## Active ingredients

- BICTEGRAVIR SODIUM: 75 mg/1
- LENACAPAVIR SODIUM: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-3601"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-3601
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=072a3c7e-33fb-4a87-ba21-3d8dad3f5c48